Detalles de la búsqueda
1.
How Many Tests Does It Take to Diagnose a Triple-Hit B-Lymphoblastic Lymphoma? (Hint, It's A Lot).
Pediatr Dev Pathol
; 27(2): 193-197, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38032739
2.
Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy.
Am J Transplant
; 23(3): 416-422, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36748802
3.
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells.
Blood
; 138(24): 2469-2484, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34525183
4.
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Pediatr Blood Cancer
; 69(11): e29901, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35989458
5.
Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy.
Blood
; 134(24): 2149-2158, 2019 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31697826
6.
Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy.
Ann Neurol
; 86(1): 42-54, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31074527
7.
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Biol Blood Marrow Transplant
; 25(4): 625-638, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30592986
8.
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.
Blood
; 129(25): 3322-3331, 2017 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28408462
9.
Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.
Transfusion
; 58(6): 1414-1420, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29536556
10.
Chimeric Antigen Receptor T-Cell Therapy.
J Natl Compr Canc Netw
; 16(9): 1092-1106, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30181421
11.
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
Pediatr Blood Cancer
; 65(9): e27265, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29797659
12.
Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure.
Br J Haematol
; 186(2): 333-336, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30810217
13.
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells.
Blood
; 119(1): 72-82, 2012 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-22031866
14.
Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy.
Transplant Cell Ther
; 30(5): 475-487, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447751
15.
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies.
Transplant Cell Ther
; 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38762057
16.
Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing.
J Clin Invest
; 134(9)2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38502193
17.
GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients.
Blood Adv
; 7(6): 1001-1010, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36006611
18.
Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions to Improving Efficiency of Clinical Center Certification and Maintenance of Operations for Commercially Approved Immune Effector Cell Therapies.
Transplant Cell Ther
; 29(4): 228-239, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36709800
19.
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure.
Transplant Cell Ther
; 29(9): 574.e1-574.e10, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37394115
20.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Blood Adv
; 7(4): 575-585, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482927